WebThe price decrease on the next newsis expected to be -16.88% whereas the daily expected return is currently at -1.31%. The volatility of related hype on Altamira Therapeutics is about 38276.92% with expected price after next announcement by competition of 2.42. The company has price-to-book (P/B) ratio of 0.73. WebBased on 1 Wall Street analysts offering 12 month price targets for Cytosorbents in the last 3 months. The average price target is $5.50 with a high forecast of $5.50 and a low forecast of $5.50. The average price target represents a …
CYTO Altamira Therapeutics Ltd. Stock Overview (U.S.: Nasdaq ...
WebAltamira Therapeutics reported last year Debt Current of 102,826. As of 13th of February 2024, Debt Non Current is likely to grow to about 426.3 K, while Accumulated Retained Earnings Deficit are likely to drop (170.9 M ). Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company ... WebAltamira Therapeutics Ltd. analyst estimates, including CYTO earnings per share estimates and analyst recommendations. is isothermal process adiabatic
CytoMed Therapeutics - GDTC Stock Forecast, Price & News
WebCYTO CYTO AVCT Minimum time of 15 days and a maximum of 2 months you will see a movement from these levels between 40-100% up or beyond the Setting has been studied with a risk-return accuracy of 80% ALLERT COVID-19 OMICRON VARIANT : BREAKING: U.S. reports 400,000 new coronavirus cases, the biggest CYTO AVCT Minimum time of … WebFind real-time SRNEQ - Sorrento Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. WebApr 8, 2024 · 52-week High/Low: $43 / $1.17. 50/200 Day Moving Average: $2.082 / $5.78. This figure corresponds to the Average Price over the previous 50/200 days. For … keras applications pretrained models